-
11.10.22 || Allogeneic natural killer cells engineered to express HER2-directed CAR, Interleukin 15, and TGF-beta dominant negative receptor effectively control HER2+tumors
SITC 2022 Poster presentation
Read More -
11.10.22 || Engineering CD70-Directed CAR-NK Cells for the Treatment of Hematological and Solid Malignancies
SITC 2022 Poster presentation
Read More -
05.16.22 || A Synthetic Biology Approach to Address the Immunosuppressive Tumor Microenvironment: Novel TGF-β Switch Receptors Convert Inhibitory Signals into Enhanced NK Cell Activity
ASGCT 2022 Poster presentation
Read More -
05.16.22 || Engineered Allogeneic Car-Natural Killer Cells Resist Tumor Microenvironment Immuno-Suppression by Expression of a TGFBR2 Dominant Negative Receptor
ASGCT 2022 Poster Presentation
Read More -
04.08.22 || Allogeneic Natural Killer Cells Engineered to Express HER2 CAR, Interleukin 15, and TGF-Beta Dominant Negative Receptor Effectively Control HER2+ Tumors
AACR 2022 Poster Presentation
Read More -
12.11.21 || Engineering CD70-Directed CAR-NK Cells for the Treatment of Hematological and Solid Malignancies
ASH 2021 Poster Presentation
Read More -
10.06.21 || Cryopreservation of Natural Killer and anti-CD19 Chimeric Antigen Receptor Natural Killer Cells
BMES 2021 Poster Presentation
Read More